NCT03346967

Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency

Evaluation of Autologous Adipose Derived Mesenchymal Stem Cells (AD-MSCs) Therapy on Sexual Hormone Deficiency in the Middle-aged Patients: an Open-label, Single-group Clinical Trial

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology · Academic / Other
• Sex: All
• Age: 35 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and effectiveness of adipose derived mesenchymal stem cells (AD-MSCs) therapy on sexual hormone deficiency in the middle-aged patients

Detailed description

The purpose of this study is to evaluate the safety and efficiency of adipose-derived mesenchymal stem cells in 30 patients with sexual hormone deficiency at Vinmec International Hospital, Hanoi, Vietnam

Conditions

• Hormone Deficiency

Interventions

Type	Name	Description
COMBINATION_PRODUCT	adipose-derived mesenchymal stem cells	Collect adipose-derived mesenchymal stem cells from the patients. Adipose-derived mesenchymal stem cells will be isolated, expanded and characterized in vitro under the GMP- grade procedure

Timeline

• Start date: 2017-11-01
• Primary completion: 2020-02-28
• Completion: 2020-03-30
• First posted: 2017-11-20
• Last updated: 2024-06-04

Locations

1 site across 1 country: Vietnam